ProbeX Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.8M

ProbeX General Information

Description

Developer of molecular imaging technology. The company develops, manufactures, and distributes molecular imaging probe reagents for drug discovery.

Contact Information

Website
www.probex.jp/english/index.html
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1-5-5 Minatojima-Minamimachi
  • Chuo-ku
  • Kobe, 650-0047
  • Japan
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Biotechnology
Acquirer
Carna Biosciences
Vertical(s)
Manufacturing
Corporate Office
  • 1-5-5 Minatojima-Minamimachi
  • Chuo-ku
  • Kobe, 650-0047
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProbeX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Oct-2013 $2.8M 00.00 Completed Generating Revenue
2. Early Stage VC 22-Feb-2008 Completed Startup
1. Early Stage VC Completed Startup
To view ProbeX’s complete valuation and funding history, request access »

ProbeX Patents

  • 15

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

ProbeX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140141416-A1 Method for highly sensitive detection of protein-protein interaction Active 29-May-2009 00000000 0
EP-2436764-A1 Method for highly sensitive detection of protein-protein interaction Active 29-May-2009 00000000 0
US-20120190824-A1 Method for highly sensitive detection of protein-protein interaction Active 29-May-2009 0000000000 0
US-9540678-B2 Method for highly sensitive detection of protein-protein interaction Active 29-May-2009 0000000000 0
US-8470974-B2 Method for highly sensitive detection of protein-protein interaction Active 29-May-2009 C12Q1/66 0
To view ProbeX’s complete patent history, request access »

ProbeX Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fast Track Initiative Venture Capital Minority 000 0000 000000 0
To view ProbeX’s complete investors history, request access »

Ready to get started?

Request a free trial

ProbeX FAQs

  • When was ProbeX founded?

    ProbeX was founded in 2006.

  • Where is ProbeX headquartered?

    ProbeX is headquartered in Kobe, Japan.

  • What industry is ProbeX in?

    ProbeX’s primary industry is Other Healthcare Services.

  • Is ProbeX a private or public company?

    ProbeX is a Private company.

  • What is the current valuation of ProbeX?

    The current valuation of ProbeX is 00.00.

  • What is ProbeX’s current revenue?

    The current revenue for ProbeX is 00000.

  • Who are ProbeX’s investors?

    Fast Track Initiative has invested in ProbeX.

  • When was ProbeX acquired?

    ProbeX was acquired on 01-Oct-2013.

  • Who acquired ProbeX?

    ProbeX was acquired by Carna Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »